Last Price
0.003
Today's Change
-0.001 (25.00%)
Day's Change
0.003 - 0.004
Trading Volume
213,432
Overview
Market Cap
11 Million
Shares Outstanding
3 Billion
Avg Volume
7,469,004
Avg Price (50 Days)
0.00
Avg Price (200 Days)
0.00
PE Ratio
-0.30
EPS
-0.01
Earnings Announcement
04-Feb-2025
Previous Close
0.00
Open
0.00
Day's Range
0.003 - 0.004
Year Range
0.002 - 0.0085
Trading Volume
213,432
Price Change Highlight
1 Day Change
-25.00%
5 Day Change
0.00%
1 Month Change
0.00%
3 Month Change
-25.00%
6 Month Change
-50.00%
Ytd Change
-57.14%
1 Year Change
-57.14%
3 Year Change
-89.66%
5 Year Change
-88.46%
10 Year Change
-98.57%
Max Change
-99.40%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Apps
Top Articles
1
CEO Morning Brief
Qantas Faces Hefty Payout to Workers Illegally Fired in Pandemic
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
